Oct 28, 2021 / 07:00PM GMT
Michael Murray - Benzinga - VP, Marketing and Capital Partnerships
Next presentation, our final speakers of the day two presenters from our last company at the Small Cap Conference, we are bringing in Marcel Conrad, the CFO; and Ken d'Entremont, the CEO and Director of
Ken d'Entremont - Medexus Pharmaceuticals, Inc. - CEO & Director
Medexus Pharmaceuticals.
Michael Murray - Benzinga - VP, Marketing and Capital Partnerships
There it is. And my notes were missing. And that's Medexus Pharmaceutical. Guys, thank you for filling in there. Excited to have you both with us. Thank you for being here. If we can get the presentation up, I'm going to let you, gentlemen, take it away and go back and forth and run us through this. Awesome.
Ken d'Entremont - Medexus Pharmaceuticals, Inc. - CEO & Director
Perfect. So this is a little different from the last two presentations that at least I heard. This is a healthcare business, obviously, a
Medexus Pharmaceuticals Inc at Benzinga Global Small Cap Conference (Virtual) Transcript
Feb 14, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers